Italy · Series A startup

Who invested in Medical Microinstruments

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$25Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $25MApr 2018
Investors
4
See who backed them

The rounds

  1. Apr 2018
    Series A$25M
    • Andera Partners/ Panakes
    • Fountain Healthcare. Sambatech
    • Gus Castello
    • John Engels

    Reported by FinSMEs

Everyone who backed them

Andera Partners/ Panakesno record of our own yet1round
Fountain Healthcare. Sambatechno record of our own yet1round
Gus Castellono record of our own yet1round
John Engelsno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Medical Microinstruments

Who invested in Medical Microinstruments?

Medical Microinstruments's investors include Andera Partners/ Panakes, Fountain Healthcare. Sambatech, Gus Castello and John Engels.

How much has Medical Microinstruments raised?

Medical Microinstruments has raised $25M across 1 round since 2018.

When did Medical Microinstruments last raise?

Medical Microinstruments's most recent round was a Series A of $25M in Apr 2018.

What was Medical Microinstruments's biggest round?

Its most recent round, $25M in Apr 2018, is also its largest on record.

Who backed Medical Microinstruments first?

Medical Microinstruments's first round on record, in Apr 2018, was backed by Andera Partners/ Panakes, Fountain Healthcare. Sambatech and Gus Castello and 1 others.

What stage is Medical Microinstruments at?

Medical Microinstruments's latest named round is a Series A, in Apr 2018.

Where is Medical Microinstruments based?

Medical Microinstruments is based in Italy.

Companies like Medical Microinstruments

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.